Biography

Victor Bulto has served as a director of the Company since December 1, 2025. Mr. Bulto is President of Novartis US and a member of the Novartis Executive Committee since April 2022. In this role, he leads a bold strategy to reimagine medicine and improve patient care in the world’s largest healthcare market. Mr. Bulto has spearheaded commercial transformation and championed the integration of technology, advanced analytics, real-world evidence and early detection strategies to accelerate access and improve patient outcomes.

With more than two decades at Novartis, he has held senior roles across major therapeutic areas and several geographies, including President of U.S. Pharmaceuticals, Head of U.S. Alcon Pharmaceuticals, and Head of the Neuroscience Franchise for Region Europe.

Mr. Bulto holds a Master’s in Health Economics and Pharmacoeconomics and a Postgraduate Degree in Pharmaceutical Marketing from Universitat Pompeu Fabra. He earned his MBA from ESADE and completed the Advanced Management Program at Harvard Business School. He also holds a Master’s in Chemical Engineering and a Bachelor of Science in Chemistry from Institut Químic de Sarrià in Spain.